id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2012-E-1226-0006,FDA,FDA-2012-E-1226,"Determination of Regulatory Review Period for Purposes of Patent
Extension; PICATO",Notice,General Notice,2014-05-20T04:00:00Z,2014,5,2014-05-20T04:00:00Z,,2014-05-20T14:10:27Z,2014-11521,0,0,0900006481705835
FDA-2012-E-1226-0005,FDA,FDA-2012-E-1226,Letter to U. S. Patent and Trademark Office,Other,Letter(s),2014-05-12T04:00:00Z,2014,5,2014-05-12T04:00:00Z,,2024-03-12T12:12:42Z,,0,0,09000064816f29c3
FDA-2012-E-1226-0004,FDA,FDA-2012-E-1226,Letter from U.S. Patent and Trademark Office  to FDA CDER,Other,Letter(s),2014-03-28T04:00:00Z,2014,3,2014-03-28T04:00:00Z,,2014-03-28T19:53:13Z,,0,0,090000648168cf76